{
  "dataset": {
    "name": "GLP-1 Drug Shortage Monitor",
    "url": "https://nphla.com/trackers/glp1-shortage-monitor",
    "description": "FDA drug-shortage status for semaglutide, tirzepatide and liraglutide products, package by package, as published in FDA’s drug shortage data — with every status change recorded since tracking began.",
    "publisher": "National Pharmacy Health & Leadership Alliance",
    "howToCite": "National Pharmacy Health & Leadership Alliance (NPHLA). nphla.com. “GLP-1 Drug Shortage Monitor.” Updated Oct 1, 2026. https://nphla.com/trackers/glp1-shortage-monitor. Accessed October 1, 2026.",
    "kind": "Drug shortage monitor (FDA)",
    "dataOrigin": "NPHLA analysis of public data",
    "jurisdiction": "United States (federal)",
    "methodology": "The Intelligence pipeline queries openFDA’s drug shortages endpoint for the generic names semaglutide, tirzepatide and liraglutide on the schedule set in the Source Registry. Each status update FDA publishes for a package (identified by its NDC) is stored as a separate record, dated with FDA’s update date.\n\nThis tracker shows the most recent status for each package and notes when it differs from the previous status recorded. Statuses are FDA’s own wording. Nothing is edited by hand. FDA’s Drug Shortages database (https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm) is the authoritative source.",
    "coverage": "U.S. federal (FDA). Only the three generic names above; other drugs in shortage are not included. History begins when tracking of this source began.",
    "limitations": "openFDA data can lag FDA’s Drug Shortages database, and each check returns a limited number of records, so a recent change may appear late. A package that FDA removes from its data keeps its last recorded status here. The status is FDA’s, not an assessment of supply in any market. Not medical or legal advice.",
    "updateFrequency": "Checked about every 6 hours, as configured in the Source Registry.",
    "selection": "Official records (drug shortage) from primary sources.",
    "systemCheckedAt": "2026-10-01T15:35:02.886Z",
    "editoriallyReviewedAt": null,
    "editorialReview": "pending",
    "generatedAt": "2026-10-01T19:36:08.267Z",
    "recordCount": 13,
    "notAdvice": "Professional information compiled from public sources. Not medical, legal or regulatory advice; always confirm in the primary source."
  },
  "columns": [
    {
      "key": "company",
      "label": "Company"
    }
  ],
  "records": [
    {
      "key": "shortage:0169-4060-13",
      "record": "Liraglutide Injection",
      "subtitle": "Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-13)",
      "detail": "Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-13). Company: Novo Nordisk, Inc.. Estimated shortage duration: TBD",
      "status": "Current",
      "fields": {
        "recordType": "Drug shortage",
        "publisher": "U.S. Food and Drug Administration (Drug Shortages)",
        "company": "Novo Nordisk, Inc.",
        "presentation": "Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-13)",
        "ndc": "0169-4060-13"
      },
      "jurisdiction": "US",
      "date": "2026-09-22T00:00:00.000Z",
      "dateType": "FDA status update",
      "source": {
        "title": "Drug shortage update: Liraglutide Injection — Current",
        "url": "https://api.fda.gov/drug/shortages.json?search=package_ndc%3A%220169-4060-13%22",
        "publisher": "U.S. Food and Drug Administration (Drug Shortages)",
        "type": "Official record"
      },
      "lastChecked": "2026-10-01T09:05:11.471Z",
      "checkedBy": "system",
      "nphlaUpdatedAt": "2026-10-01T09:05:26.133Z",
      "change": {
        "note": "FDA status update published",
        "at": "2026-09-22T00:00:00.000Z",
        "withinLast7Days": false
      },
      "origin": "automated"
    },
    {
      "key": "shortage:0169-4060-12",
      "record": "Liraglutide Injection",
      "subtitle": "Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-12)",
      "detail": "Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-12). Company: Novo Nordisk, Inc.. Estimated shortage duration: TBD",
      "status": "Current",
      "fields": {
        "recordType": "Drug shortage",
        "publisher": "U.S. Food and Drug Administration (Drug Shortages)",
        "company": "Novo Nordisk, Inc.",
        "presentation": "Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-12)",
        "ndc": "0169-4060-12"
      },
      "jurisdiction": "US",
      "date": "2026-09-22T00:00:00.000Z",
      "dateType": "FDA status update",
      "source": {
        "title": "Drug shortage update: Liraglutide Injection — Current",
        "url": "https://api.fda.gov/drug/shortages.json?search=package_ndc%3A%220169-4060-12%22",
        "publisher": "U.S. Food and Drug Administration (Drug Shortages)",
        "type": "Official record"
      },
      "lastChecked": "2026-10-01T09:05:11.471Z",
      "checkedBy": "system",
      "nphlaUpdatedAt": "2026-10-01T09:05:26.341Z",
      "change": {
        "note": "FDA status update published",
        "at": "2026-09-22T00:00:00.000Z",
        "withinLast7Days": false
      },
      "origin": "automated"
    },
    {
      "key": "shortage:0480-3667-22",
      "record": "Liraglutide Injection",
      "subtitle": "Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-22)",
      "detail": "Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-22). Company: Novo Nordisk, Inc.. Distributed by Teva",
      "status": "Current",
      "fields": {
        "recordType": "Drug shortage",
        "publisher": "U.S. Food and Drug Administration (Drug Shortages)",
        "company": "Novo Nordisk, Inc.",
        "presentation": "Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-22)",
        "ndc": "0480-3667-22"
      },
      "jurisdiction": "US",
      "date": "2026-09-22T00:00:00.000Z",
      "dateType": "FDA status update",
      "source": {
        "title": "Drug shortage update: Liraglutide Injection — Current",
        "url": "https://api.fda.gov/drug/shortages.json?search=package_ndc%3A%220480-3667-22%22",
        "publisher": "U.S. Food and Drug Administration (Drug Shortages)",
        "type": "Official record"
      },
      "lastChecked": "2026-10-01T09:05:11.471Z",
      "checkedBy": "system",
      "nphlaUpdatedAt": "2026-10-01T09:05:26.683Z",
      "change": {
        "note": "FDA status update published",
        "at": "2026-09-22T00:00:00.000Z",
        "withinLast7Days": false
      },
      "origin": "automated"
    },
    {
      "key": "shortage:0169-2800-15",
      "record": "Liraglutide Injection",
      "subtitle": "Saxenda, Injection, 6 mg/1 mL (NDC 0169-2800-15)",
      "detail": "Saxenda, Injection, 6 mg/1 mL (NDC 0169-2800-15). Company: Novo Nordisk, Inc.. Product will be available until discontinuation in January 2027",
      "status": "Current",
      "fields": {
        "recordType": "Drug shortage",
        "publisher": "U.S. Food and Drug Administration (Drug Shortages)",
        "company": "Novo Nordisk, Inc.",
        "presentation": "Saxenda, Injection, 6 mg/1 mL (NDC 0169-2800-15)",
        "ndc": "0169-2800-15"
      },
      "jurisdiction": "US",
      "date": "2026-09-22T00:00:00.000Z",
      "dateType": "FDA status update",
      "source": {
        "title": "Drug shortage update: Liraglutide Injection — Current",
        "url": "https://api.fda.gov/drug/shortages.json?search=package_ndc%3A%220169-2800-15%22",
        "publisher": "U.S. Food and Drug Administration (Drug Shortages)",
        "type": "Official record"
      },
      "lastChecked": "2026-10-01T09:05:11.471Z",
      "checkedBy": "system",
      "nphlaUpdatedAt": "2026-10-01T09:05:27.181Z",
      "change": {
        "note": "FDA status changed from “To Be Discontinued”",
        "at": "2026-09-22T00:00:00.000Z",
        "withinLast7Days": false
      },
      "origin": "automated"
    },
    {
      "key": "shortage:0480-3667-20",
      "record": "Liraglutide Injection",
      "subtitle": "Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-20)",
      "detail": "Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-20). Company: Novo Nordisk, Inc.. Distributed by Teva",
      "status": "Current",
      "fields": {
        "recordType": "Drug shortage",
        "publisher": "U.S. Food and Drug Administration (Drug Shortages)",
        "company": "Novo Nordisk, Inc.",
        "presentation": "Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-20)",
        "ndc": "0480-3667-20"
      },
      "jurisdiction": "US",
      "date": "2026-09-22T00:00:00.000Z",
      "dateType": "FDA status update",
      "source": {
        "title": "Drug shortage update: Liraglutide Injection — Current",
        "url": "https://api.fda.gov/drug/shortages.json?search=package_ndc%3A%220480-3667-20%22",
        "publisher": "U.S. Food and Drug Administration (Drug Shortages)",
        "type": "Official record"
      },
      "lastChecked": "2026-10-01T09:05:11.471Z",
      "checkedBy": "system",
      "nphlaUpdatedAt": "2026-10-01T09:05:27.405Z",
      "change": {
        "note": "FDA status update published",
        "at": "2026-09-22T00:00:00.000Z",
        "withinLast7Days": false
      },
      "origin": "automated"
    },
    {
      "key": "shortage:0143-9144-03",
      "record": "Liraglutide Injection",
      "subtitle": "Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-03)",
      "detail": "Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-03). Company: Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "fields": {
        "recordType": "Drug shortage",
        "publisher": "U.S. Food and Drug Administration (Drug Shortages)",
        "company": "Hikma Pharmaceuticals USA, Inc.",
        "presentation": "Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-03)",
        "ndc": "0143-9144-03"
      },
      "jurisdiction": "US",
      "date": "2026-09-18T00:00:00.000Z",
      "dateType": "FDA status update",
      "source": {
        "title": "Drug shortage update: Liraglutide Injection — Current",
        "url": "https://api.fda.gov/drug/shortages.json?search=package_ndc%3A%220143-9144-03%22",
        "publisher": "U.S. Food and Drug Administration (Drug Shortages)",
        "type": "Official record"
      },
      "lastChecked": "2026-10-01T09:05:11.471Z",
      "checkedBy": "system",
      "nphlaUpdatedAt": "2026-10-01T09:05:25.916Z",
      "change": {
        "note": "FDA status update published",
        "at": "2026-09-18T00:00:00.000Z",
        "withinLast7Days": false
      },
      "origin": "automated"
    },
    {
      "key": "shortage:0143-9144-02",
      "record": "Liraglutide Injection",
      "subtitle": "Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-02)",
      "detail": "Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-02). Company: Hikma Pharmaceuticals USA, Inc.",
      "status": "Current",
      "fields": {
        "recordType": "Drug shortage",
        "publisher": "U.S. Food and Drug Administration (Drug Shortages)",
        "company": "Hikma Pharmaceuticals USA, Inc.",
        "presentation": "Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-02)",
        "ndc": "0143-9144-02"
      },
      "jurisdiction": "US",
      "date": "2026-09-18T00:00:00.000Z",
      "dateType": "FDA status update",
      "source": {
        "title": "Drug shortage update: Liraglutide Injection — Current",
        "url": "https://api.fda.gov/drug/shortages.json?search=package_ndc%3A%220143-9144-02%22",
        "publisher": "U.S. Food and Drug Administration (Drug Shortages)",
        "type": "Official record"
      },
      "lastChecked": "2026-10-01T09:05:11.471Z",
      "checkedBy": "system",
      "nphlaUpdatedAt": "2026-10-01T09:05:26.968Z",
      "change": {
        "note": "FDA status update published",
        "at": "2026-09-18T00:00:00.000Z",
        "withinLast7Days": false
      },
      "origin": "automated"
    },
    {
      "key": "shortage:71288-563-85",
      "record": "Liraglutide Injection",
      "subtitle": "Liraglutide, Injection, 6 mg/1 mL (NDC 71288-563-85)",
      "detail": "Liraglutide, Injection, 6 mg/1 mL (NDC 71288-563-85). Company: Meitheal Pharmaceuticals, Inc.",
      "status": "Current",
      "fields": {
        "recordType": "Drug shortage",
        "publisher": "U.S. Food and Drug Administration (Drug Shortages)",
        "company": "Meitheal Pharmaceuticals, Inc.",
        "presentation": "Liraglutide, Injection, 6 mg/1 mL (NDC 71288-563-85)",
        "ndc": "71288-563-85"
      },
      "jurisdiction": "US",
      "date": "2026-08-27T00:00:00.000Z",
      "dateType": "FDA status update",
      "source": {
        "title": "Drug shortage update: Liraglutide Injection — Current",
        "url": "https://api.fda.gov/drug/shortages.json?search=package_ndc%3A%2271288-563-85%22",
        "publisher": "U.S. Food and Drug Administration (Drug Shortages)",
        "type": "Official record"
      },
      "lastChecked": "2026-10-01T09:05:11.471Z",
      "checkedBy": "system",
      "nphlaUpdatedAt": "2026-10-01T09:05:27.456Z",
      "change": {
        "note": "FDA status update published",
        "at": "2026-08-27T00:00:00.000Z",
        "withinLast7Days": false
      },
      "origin": "automated"
    },
    {
      "key": "shortage:71288-563-84",
      "record": "Liraglutide Injection",
      "subtitle": "Liraglutide, Injection, 6 mg/1 mL (NDC 71288-563-84)",
      "detail": "Liraglutide, Injection, 6 mg/1 mL (NDC 71288-563-84). Company: Meitheal Pharmaceuticals, Inc.",
      "status": "Current",
      "fields": {
        "recordType": "Drug shortage",
        "publisher": "U.S. Food and Drug Administration (Drug Shortages)",
        "company": "Meitheal Pharmaceuticals, Inc.",
        "presentation": "Liraglutide, Injection, 6 mg/1 mL (NDC 71288-563-84)",
        "ndc": "71288-563-84"
      },
      "jurisdiction": "US",
      "date": "2026-08-27T00:00:00.000Z",
      "dateType": "FDA status update",
      "source": {
        "title": "Drug shortage update: Liraglutide Injection — Current",
        "url": "https://api.fda.gov/drug/shortages.json?search=package_ndc%3A%2271288-563-84%22",
        "publisher": "U.S. Food and Drug Administration (Drug Shortages)",
        "type": "Official record"
      },
      "lastChecked": "2026-10-01T09:05:11.471Z",
      "checkedBy": "system",
      "nphlaUpdatedAt": "2026-10-01T09:05:27.492Z",
      "change": {
        "note": "FDA status update published",
        "at": "2026-08-27T00:00:00.000Z",
        "withinLast7Days": false
      },
      "origin": "automated"
    },
    {
      "key": "shortage:0169-4303-30",
      "record": "Semaglutide Tablet",
      "subtitle": "Rybelsus, Tablet, 3 mg (NDC 0169-4303-30)",
      "detail": "Rybelsus, Tablet, 3 mg (NDC 0169-4303-30). Company: Novo Nordisk, Inc.. Discontinuation of the manufacture of the drug. These products will be replaced by Ozempic (semaglutide) tablets.",
      "status": "To Be Discontinued",
      "fields": {
        "recordType": "Drug shortage",
        "publisher": "U.S. Food and Drug Administration (Drug Shortages)",
        "company": "Novo Nordisk, Inc.",
        "presentation": "Rybelsus, Tablet, 3 mg (NDC 0169-4303-30)",
        "ndc": "0169-4303-30"
      },
      "jurisdiction": "US",
      "date": "2026-06-04T00:00:00.000Z",
      "dateType": "FDA status update",
      "source": {
        "title": "Drug shortage update: Semaglutide Tablet — To Be Discontinued",
        "url": "https://api.fda.gov/drug/shortages.json?search=package_ndc%3A%220169-4303-30%22",
        "publisher": "U.S. Food and Drug Administration (Drug Shortages)",
        "type": "Official record"
      },
      "lastChecked": "2026-10-01T09:05:11.471Z",
      "checkedBy": "system",
      "nphlaUpdatedAt": "2026-10-01T09:05:25.779Z",
      "change": {
        "note": "FDA status update published",
        "at": "2026-06-04T00:00:00.000Z",
        "withinLast7Days": false
      },
      "origin": "automated"
    },
    {
      "key": "shortage:0169-4307-30",
      "record": "Semaglutide Tablet",
      "subtitle": "Rybelsus, Tablet, 7 mg (NDC 0169-4307-30)",
      "detail": "Rybelsus, Tablet, 7 mg (NDC 0169-4307-30). Company: Novo Nordisk, Inc.. Discontinuation of the manufacture of the drug. These products will be replaced by Ozempic (semaglutide) tablets.",
      "status": "To Be Discontinued",
      "fields": {
        "recordType": "Drug shortage",
        "publisher": "U.S. Food and Drug Administration (Drug Shortages)",
        "company": "Novo Nordisk, Inc.",
        "presentation": "Rybelsus, Tablet, 7 mg (NDC 0169-4307-30)",
        "ndc": "0169-4307-30"
      },
      "jurisdiction": "US",
      "date": "2026-06-04T00:00:00.000Z",
      "dateType": "FDA status update",
      "source": {
        "title": "Drug shortage update: Semaglutide Tablet — To Be Discontinued",
        "url": "https://api.fda.gov/drug/shortages.json?search=package_ndc%3A%220169-4307-30%22",
        "publisher": "U.S. Food and Drug Administration (Drug Shortages)",
        "type": "Official record"
      },
      "lastChecked": "2026-10-01T09:05:11.471Z",
      "checkedBy": "system",
      "nphlaUpdatedAt": "2026-10-01T09:05:26.739Z",
      "change": {
        "note": "FDA status update published",
        "at": "2026-06-04T00:00:00.000Z",
        "withinLast7Days": false
      },
      "origin": "automated"
    },
    {
      "key": "shortage:0169-4314-30",
      "record": "Semaglutide Tablet",
      "subtitle": "Rybelsus, Tablet, 14 mg (NDC 0169-4314-30)",
      "detail": "Rybelsus, Tablet, 14 mg (NDC 0169-4314-30). Company: Novo Nordisk, Inc.. Discontinuation of the manufacture of the drug. These products will be replaced by Ozempic (semaglutide) tablets.",
      "status": "To Be Discontinued",
      "fields": {
        "recordType": "Drug shortage",
        "publisher": "U.S. Food and Drug Administration (Drug Shortages)",
        "company": "Novo Nordisk, Inc.",
        "presentation": "Rybelsus, Tablet, 14 mg (NDC 0169-4314-30)",
        "ndc": "0169-4314-30"
      },
      "jurisdiction": "US",
      "date": "2026-06-04T00:00:00.000Z",
      "dateType": "FDA status update",
      "source": {
        "title": "Drug shortage update: Semaglutide Tablet — To Be Discontinued",
        "url": "https://api.fda.gov/drug/shortages.json?search=package_ndc%3A%220169-4314-30%22",
        "publisher": "U.S. Food and Drug Administration (Drug Shortages)",
        "type": "Official record"
      },
      "lastChecked": "2026-10-01T09:05:11.471Z",
      "checkedBy": "system",
      "nphlaUpdatedAt": "2026-10-01T09:05:27.529Z",
      "change": {
        "note": "FDA status update published",
        "at": "2026-06-04T00:00:00.000Z",
        "withinLast7Days": false
      },
      "origin": "automated"
    },
    {
      "key": "shortage:0480-7250-46",
      "record": "Liraglutide Injection",
      "subtitle": "Liraglutide, Injection, 6 mg/1 mL (NDC 0480-7250-46)",
      "detail": "Liraglutide, Injection, 6 mg/1 mL (NDC 0480-7250-46). Company: Teva Pharmaceuticals USA, Inc.. Discontinuation of the manufacture of the drug",
      "status": "To Be Discontinued",
      "fields": {
        "recordType": "Drug shortage",
        "publisher": "U.S. Food and Drug Administration (Drug Shortages)",
        "company": "Teva Pharmaceuticals USA, Inc.",
        "presentation": "Liraglutide, Injection, 6 mg/1 mL (NDC 0480-7250-46)",
        "ndc": "0480-7250-46"
      },
      "jurisdiction": "US",
      "date": "2026-05-14T00:00:00.000Z",
      "dateType": "FDA status update",
      "source": {
        "title": "Drug shortage update: Liraglutide Injection — To Be Discontinued",
        "url": "https://api.fda.gov/drug/shortages.json?search=package_ndc%3A%220480-7250-46%22",
        "publisher": "U.S. Food and Drug Administration (Drug Shortages)",
        "type": "Official record"
      },
      "lastChecked": "2026-10-01T09:05:11.471Z",
      "checkedBy": "system",
      "nphlaUpdatedAt": "2026-10-01T09:05:25.734Z",
      "change": {
        "note": "FDA status update published",
        "at": "2026-05-14T00:00:00.000Z",
        "withinLast7Days": false
      },
      "origin": "automated"
    }
  ]
}